Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 10, 2022

BUY
$0.62 - $9.97 $124 - $1,994
200 Added 25.97%
970 $10,000
Q2 2022

Aug 10, 2022

SELL
$9.83 - $9.9 $796 - $801
-81 Reduced 9.52%
770 $8,000
Q1 2022

May 16, 2022

SELL
$9.75 - $9.85 $975 - $985
-100 Reduced 10.52%
851 $8,000
Q4 2021

Feb 14, 2022

SELL
$9.72 - $9.84 $1,944 - $1,968
-200 Reduced 17.38%
951 $9,000
Q3 2021

Nov 15, 2021

SELL
$9.66 - $10.0 $17,658 - $18,280
-1,828 Reduced 61.36%
1,151 $11,000
Q2 2021

Aug 13, 2021

BUY
$9.7 - $10.14 $28,896 - $30,207
2,979 New
2,979 $29,000

About Frazier Lifesciences Acquisition Corp


  • Ticker FLAC
  • Exchange NASDAQ
  • Sector Financial Services
  • Industry Shell Companies
  • Shares Outstandng 14,301,000
  • Description
  • Frazier Lifesciences Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or related business combination with one or more businesses or entities in the biotechnology sector. The company was incorporated in 2020 and is based in Seattle, Washington.
More about FLAC
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.